High prevalence of oncogenic HPV-16 in cervical smears
of asymptomatic women of eastern Uttar Pradesh,
India: A population-based study
SHIKHA SRIVASTAVA1 , SADHANA GUPTA2 and JAGAT KUMAR ROY1,*
1
Cytogenetics Laboratory, Department of Zoology, Banaras Hindu University, Varanasi 221 005, India
2
Post-Partum Out Patient Department, Sir Sunderlal Hospital, Banaras Hindu University,
Varanasi 221 005, India
*Corresponding author (Fax, +91-542-2368457; Email,
[email protected])
In developing countries like India, occurrence of Human papillomavirus (HPV) in cervical cancer as well as in the
asymptomatic population was observed to be very high. Studies on HPV prevalence have been conducted in different
parts of the country but no data were available from the eastern region of Uttar Pradesh (UP). The present study
aimed to determine the status of HPV prevalence and its association with different socio-demographic factors in this
population. Prevalence of HPV was investigated in a total of 2424 cervical scrape samples of asymptomatic women.
Primer sets from L1 consensus region of viral genome were used to detect the presence of HPV, and the positive
samples were genotyped by sequencing. Univariate binary logistic regression analysis was used to evaluate
association of socio-demographic factors with HPV. 9.9% of the clinically asymptomatic women were found to be
infected with HPV comprising 26 different genotypes. Among HPV-positive women, 80.8% showed single infection,
while 15.4% harboured multiple infections. HPV-16 (63.7%) was the most prevalent, followed by HPV-31 (6.7%),
HPV-6 (5.4%), HPV-81 (4.6%) and HPV-33 (4.2%). Significant association of HPV with non-vegetarian diet (P<0.05)
and rural residential areas (P<0.01) were observed. High prevalence of HPV-16 in asymptomatic women of this
population, a frequency comparable to invasive cervical cancers, highlights an urgent need for a therapeutic HPV
vaccine covering HPV-16 and other high-risk types to provide protection against the disease.
[Srivastava S, Gupta S and Roy JK 2012 High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern Uttar
Pradesh, India: A population-based study. J. Biosci. 37 63–72] DOI 10.1007/s12038-012-9181-y
1.
Introduction
Cervical cancer, the second most common gynaecological
malignancy worldwide, has been reported to occur in
abundance in different populations. According to World
Health Organization (WHO 2010), in India approximately
1,34,420 women are diagnosed with the disease every year,
and of them 72,825 die. The major causative factor of the
disease is understood to be Human papillomavirus (HPV), a
double-stranded DNA virus. More than 100 HPV types are
known to occur that are categorized into three broad
categories depending upon their oncogenic potential: highKeywords.
risk types including HPV-16, -18, -31, -33, -35, -39, -45,
-51, -52, -56, -58, -59, -68, -73 and -82; intermediate types
including HPV-26, -53, -66 and low-risk types including
HPV-6, -11, -40, -42, -43, -44, -54, -61, -70, -72, -81
and -CP6108 (Munoz et al. 2003). Infection with high-risk
HPV types is the critical aetiological factor in the development of cervical cancer. Certain cervical intraepithelial neoplasias (CINs) with persistent HPV infection progress to
invasive cervical cancer although a fraction of them regress
during the course of time – 60% in case of CIN-1, 40% of
CIN-2 and 33% of CIN-3 (Ostor 1993). Approximately 40%
of all CINs persist and only about 1% of CIN-1, 5% of CIN-2
Asymptomatic; cervix cancer; HPV; HPV genotypes; socio-demographic factors
Abbreviations used: CI, confidence interval; CIN, cervical intraepithelial neoplasia; HPV, Human papillomavirus; OR, odds ratio
http://www.ias.ac.in/jbiosci
Published online: 27 January 2012
J. Biosci. 37(1), March 2012, 63–72, * Indian Academy of Sciences
63
64
S Srivastava, S Gupta and JK Roy
and 15% of CIN-3 advanced to invasive cancers (Ostor
1993). Since only a certain fraction of HPV-infected CINs
progress to invasive cancer after a long latent period and
the incidence of tumours are less frequent than the HPV
infection, additional events also play crucial role in making
HPV infection persistent, leading to oncogenicity. These
cofactors may be genetic, immunological as well as sociodemographic, e.g., lower age of conception, high parity,
use of oral contraceptives, diet, smoking, etc. It was also
evidenced that women co-infected with multiple HPV-type
infections comprising of one or more high-risk types were
prone to persistent HPV infection and hence advancement
of the disease. Although biological significance of multiple
HPV-type infection is not known, it seems that they act
synergistically accelerating the process of disease progression
(Trottier et al. 2006).
HPV-infected asymptomatic women remain at risk of
developing the disease, and hence its screening is indispensable. Many studies have been performed in different
populations of India to determine the prevalence of HPV
and their types but no study has yet been reported on the
eastern UP population. Therefore, this study was designed
to determine the prevalence of HPV and its genotypes in
asymptomatic women of Varanasi and adjoining areas and
also to study the different risk factors involved in the
persistence of the virus and progression of the disease.
2.
Materials and methods
2.1
Study group
After obtaining institutional ethical clearance, cervical
scrape samples were collected from women visiting the
Post-Partum Out Patient Department (PP-OPD) of Sir
Sunderlal Hospital, Varanasi between October 2005 and
December 2010 for family planning, medical termination of
pregnancy or for routine gynaecological examination.
Several healthcare camps were also organized in the nearby
villages to collect the samples from women living in rural
areas. All the women were physically examined and cervical
scrape samples were collected and stored for HPV testing.
The women selected were asymptomatic with no previous
history of HPV infection or any cervical neoplasia and were
clinically normal. Unmarried women, women in their
second or third trimester of pregnancy or with past history
of hysterectomy were not included in the study. Since HPV
infection is a sexually transmitted disease, there were less
chances of infection in unmarried women and, in the Indian
scenario, it is not possible to get the correct information
regarding premarital sexuality. Consent was taken from
each of the participants included in the study. A questionnaire form consisting of questions related to different sociodemographic factors including age of women, marital status,
parity, age of conception, diet, socio-economic status, place of
residence, history of any disease or HPV infection, pre and
post-menopause status and pregnancy were filled and recorded
for each participant.
2.2
Sample collection and DNA extraction
After pelvic examination, exfoliated cells from the ectocervix
region were collected from each woman using a wooden
Ayers’ spatula. For sample collection, Ayers’ spatula was
inserted in the cervix using its long arm and rotated in
clockwise direction. A total of 2480 women aged 17 to
80 years were examined and samples were collected in 5 mL
Table 1. Oligonucleotide sequences used as primers for detection of HPV and its different types
S. No.
Primer sequence (5′-3′)
Ann Temp
Region
Product size (bp)
MY09/11
FP- GCM CAG GGW CAT AAY AAT GG
RP- CAA CTT CAT CCA CGT TAC ACC
FP- AAT GCC TGT GTT CAT TGC TG
RP- TTC AAG GTC AGC CCC TAC AC
FP- AAG GCC AAC TAA ATG TCA C
RP- CTG CTT TTA TAC TAA CCG G
FP- TGA GGT ACC ATT CGA TAT TT
RP- TAG CAA AAA GCT GCT TCA CGC
FP- TAA GCT CGG CAT TGG AAA TAC CCT
RP- CCT TCC TCC TAT GTT GTG GAA TCG
FP- AAC GCC ATG AGA GGA CAC AAG
RP- ACA CAT AAA CGA ACT GTG GTG
FP- CCCGAGGCAACTGACCTATA
RP- GGGGCACACTATTCCAAATG
FP- GAA GAG CCA AGG ACA GGT AC
RP- CAA CTT CAT CCA CGT TAC ACC
50°C
L1
450
38°C
L1
150
50°C
LCR
217
51°C
L1
118
55°C
E6
350
58°C
E7
211
57°C
E7
230
GP 5+/6+
HPV 16
HPV 18
HPV 31
HPV 33
HPV 35
β-globin
J. Biosci. 37(1), March 2012
55°C
268
High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern UP
pre-chilled PBS, immediately kept on ice, transported to the
lab and stored at −70°C until further use. DNA was extracted
from each cervical scrape sample according to the protocol
previously described by Gravitt et al. (1998). Briefly, samples
were vortexed properly to dislodge the cells from the spatula,
centrifuged at 3000 rpm, and the pellet was resuspended in
600 μL of lysis buffer (0.3% SDS, 1xTE) and incubated with
80 μg of proteinase K at 55°C for 16 h. Then extractions
were performed using phenol:chloroform:isoamyl alcohol
and chloroform:isoamyl alcohol, and the DNA was
precipitated with 1/10 volume of 3 M sodium acetate and
Table 2. Frequency of high- and low-risk HPV types detected in
240 HPV-infected women
HPV type
High-risk type
16
18
31
33
35
39
45
51
56
58
59
67
68
72
73
Low-risk type
6
11
41
42
54
61
70
81
86
90
Intermediaterisk type
66
Multiple
infections
Not genotyped
Total positive
No. of women No. of women Total no. of
with single
with multiple HPV-infected
HPV infection HPV infections women (%)
166 (69.2%)
133
6
4
6
2
1
2
1
3
3
2
1
1
1
0
26 (10.8%)
7
3
0
3
1
1
1
7
1
2
2
37 (15.4%)
20
3
12
4
5
0
2
3
1
1
2
2
0
1
2
153 (63.7)
9 (3.7)
16 (6.7)
10 (4.2)
7 (2.9)
1 (0.4)
4 (1.7)
4 (1.7)
4 (1.7)
4 (1.7)
4 (1.7)
3 (1.2)
1 (0.4)
2 (0.8)
2 (0.8)
6
2
1
3
0
0
0
4
2
1
13 (5.4)
5 (2.1)
1 (0.4)
6 (2.5)
1 (0.4)
1 (0.4)
1 (0.4)
11 (4.6)
3 (1.2)
3 (1.2)
2
4 (1.7)
10 (4.2%)
240 (9.9)
65
0.7 volume of isopropanol, dried and dissolved in TE
(Tris-EDTA, pH 8.0) buffer. Samples were electrophoresed
on 1% agarose gel to check the quality of the DNA.
Quantification of the samples was carried out using
Nanodrop spectrophotometer (Nanodrop, ND-1000).
2.3
HPV detection by PCR
PCR was first performed for human β-globin gene, which
serves as an internal control to check the integrity and
adequacy of DNA. The primer set used for the amplification
of β-globin gene was PC04 and GH20 (Vossler et al. 1995),
which generate a 268 bp amplicon. Samples negative for
β-globin gene were excluded from further analysis. PCR for
HPV detection was carried out using MY09/11 (Baay et al.
1996) and GP5+/6+ (Evans et al. 2005) primers of L1
consensus region. 25 μL of reaction containing 50 ng DNA
samples, 10 pmol of each forward and reverse primers, 4 μL
of dNTP mix (containing 200 μM each of dATP, dTTP,
dCTP and dGTP), and 0.3 U of Taq polymerase (Bangalore
Genie) was set up in 1X PCR buffer (10 mM Tris Cl pH 8.3,
50 mM KCl, 1.5 mM MgCl2) provided along with the
enzyme. Positive and negative controls were kept in each
reaction along with the samples. Positive controls used were
known HPV-positive DNA, and the reaction without DNA
serves as negative control. DNA was amplified using
thermocycler (Applied Biosystems) and the PCR products
were checked on 2% agarose gel having ethidium bromide
under UV transilluminator. A 450 bp amplicon was detected
Figure 1. Agarose gel showing amplification of different HPV
genotypes in cervical scrape samples using type-specific primers.
M: pUC12-HinfI marker, S1: HPV-16 (217 bp), S2: HPV-18
(118 bp), S3: HPV-31 (350 bp), S4: HPV-33 (211 bp), S5: HPV35 (230 bp).
J. Biosci. 37(1), March 2012
66
S Srivastava, S Gupta and JK Roy
with MY09/MY11 and 150 bp with GP5+/6+ primer sets,
respectively. Primer sequences used are given in table 1.
2.4
HPV genotyping
HPV-positive PCR amplicons were excised from agarose gel
and purified using Gel extraction kit (Fermentas, USA)
according to the manufacturer’s protocol. The purified
products were subjected to automated DNA sequencer
(Applied Biosystems 3130 four capillary Genetic Analyser;
ABI, USA) using Big Dye terminator v1.1 cycle sequencing
kit (ABI) according to the manufacturer’s protocol. GP6+
primer was used for sequencing as it detects a 34 to 50 bp
hyper-variable region upstream to GP5+ primer site. It can be
used as a signature sequence for most of the HPV types except
for some variants (Lee et al. 2009). Sequence alignment was
done by ClustalW and NCBI BLAST algorithm. Samples
showing more than 95% identities with the GenBank
database were considered as matched genotypes. Samples
showing multiple genotypes were differentiated by the
presence of overlapping peaks. Mixed infections were
verified using type-specific primers of HPV-16, -18, -31
(Vinayagamoorthy et al. 2003), -33 and -35 (Karlsen et al.
1996). Clones for HPV-31, -33 and -35 were used as positive
controls during the PCR, while known HPV-positive DNA
samples were used as positive control for HPV-16 and -18.
2.5
Statistical analysis
Data were statistically analysed using SPSS statistical
software (version 16.0). Univariate binary logistic regression analysis was performed to assess the strength of
association of HPV and different demographic factors. Odds
ratio at 95% confidence interval was calculated. The tests
were considered significant if P-value is ≤0.05. Stepwise
backward logistic regression analysis was performed to
evaluate the most significantly associated factors.
3.
Results
A total of 2480 women participants were screened for HPV
infection; however, samples of 56 women were excluded
due to negative results for β-globin. From each woman
complete questionnaire form along with the consent was
collected. All samples were first analysed for HPV
positivity by PCR using L1 consensus primer sets, and then
the amplified regions were sequenced to detect the
genotypes. Samples with multiple infections were further
confirmed by PCR using type-specific primers. Table 2
gives a summarized picture of different HPV types detected
in the analysed population and a representative picture of
J. Biosci. 37(1), March 2012
PCR-amplified products is shown in figure 1. In total, 240
(9.9%) women were found to acquire HPV infection
although genotyping for 10 samples was not done due to
inadequate DNA amount. Twenty-six different HPV genotypes were detected including 15 high-risk, 10 low-risk and
1 intermediate-risk types. 166 (69.2%) women were infected
with single high-risk HPV-type, while single low-risk and
intermediate-risk types were 26 (10.8%) and 2 (0.8%),
respectively. Multiple infections comprising two or three
different HPV types were observed in 37 (15.4%) women.
Infection with two different types of HPV was more
common than with three or more types of infection (table 3).
HPV-16 was observed to be the most prevalent high-risk
types (63.7%) comprising both single and multiple infections followed by HPV-31 (6.7%), HPV-33 (4.2%) and
HPV-18 (3.7%) in the high-risk group. In the low-risk group
HPV-6 (5.4%) and HPV-81 (4.6%) were the most frequent
types, followed by HPV-42 (2.5%) and HPV-11 (2.1%).
Table 4 gives a closer look of the data showing presence
of HPV in relation to different socio-demographic parameters. The different factors taken into consideration were age
Table 3. Distribution of multiple HPV genotypes present in
HPV-infected women
Multiple HPV
types
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
HPV
16/18
16/31
16/33
16/42
16/90
16/11
33/35
51/35
59/45
59/73
18/56
35/51
58/86
42/73
81/66
6/66
6/67
6/81
16/18/72
16/45/86
16/6/67
35/6/42
33/35/11
81/51/41
No. of infected
women
% of infected
women
1
12
1
1
1
1
2
1
1
1
1
1
1
1
1
1
1
2
1
1
1
1
1
1
0.4
5.0
0.4
0.4
0.4
0.4
0.8
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.8
0.4
0.4
0.4
0.4
0.4
0.4
High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern UP
67
Table 4. Association of selected socio-demographic parameters with HPV-positive and HPV-negative women using univariate binary
logistic regression analysis
Socio-demographic factors
Age (years)
≤25
26–35
36–45
≥46
Parity
0–1
2
3
≥4
Age at first intercourse (years)
≤ 20
>20
Place of residence
Rural
Urban
Diet
Non-veg
Veg
Income group
Low
Middle
Pregnancy
Yes
No
Menopause
Pre
Post
a
No. of casesa
HPV-positive
% infection
Odds ratio (CI 95%)
P-value
742
1298
249
109
68
126
30
15
9.2
9.7
12.0
13.7
0.68 (0.38–1.22)
0.72 (0.41–1.25)
0.88 (0.46–1.68)
1.0 (reference)
0.19
0.24
0.70
435
794
580
598
45
60
61
73
10.3
7.5
10.5
12.2
1.0 (reference)
0.67 (0.45–0.99)
0.95 (0.64 –1.41)
1.09 (0.74 –1.61)
1152
1115
127
112
11.0
10.0
1.12 (0.86–1.46)
1.0 (reference)
0.38
1086
1307
129
108
11.8
8.3
1.42 (1.08–1.85)
1.0 (reference)
0.01
1229
1158
137
102
11.1
8.8
1.31 (0.99–1.72)
1.0 (reference)
0.05
1049
1342
117
109
11.1
8.1
1.22 (0.93–1.59)
1.0 (reference)
0.15
385
2024
46
193
11.9
9.5
1.22 (0.86–1.72)
1.0 (reference)
0.26
2280
136
222
17
9.7
12.5
0.75 (0.45–1.25)
1.0 (reference)
0.27
0.05
0.79
0.66
Due to some missing data, numbers may not add up to total.
of the women, diet, place of residence, income groups,
parity, age at first intercourse, pre- and post-menopause
status and pregnancy (Ist trimester). Univariate binary as
well as backward logistic regression analysis results showed
diet and place of residence as the significantly associated
factors with HPV infection. Women taking non-vegetarian
diet showed higher association (P≤0.05) with HPV than
women taking vegetarian diet. Further, women belonging
to rural population showed significant association with
HPV infection (P≤0.01) in comparison to women living in
urban areas.
A non-significant positive association of HPV with parity
was observed, indicating an increase in risk of HPV
infection with the increase in number of births, while
women having two pregnancies with the lowest OR value
(0.67) were found to show the least association with HPV
(P≤0.05). An increase in association of HPV infection was
also observed with the increase in age of the women.
Although not statistically significant, pregnant women
(11.9%) and women belonging to lower income group
(11.1%) showed high percentage of HPV infection, consequently making them a highly susceptible group. Interestingly, post-menopausal women showed greater risk of
infection (12.5%) in comparison with pre-menopausal
women (9.7%). Although women in their pre-menopausal
status were inversely correlated to HPV infection (OR=
0.75; 95% CI 0.45–1.25), showing they were at low-risk
level yet they were more susceptible to low and intermediate
HPV-type infection in comparison to post-menopausal
women (figure 2A).
The frequency of HPV-16 also shows an increasing trend
with age, with lower infection in women less than 25 years
of age and increases with age, hence showing positive
correlation (figure 2B).
J. Biosci. 37(1), March 2012
68
S Srivastava, S Gupta and JK Roy
(A)
90
80
70
60
50
pre M
40
post M
30
20
10
0
High
Multiple
Low
Intermediate
HPV types
(B)
% of HPV infected women
120
100
80
High risk
60
HPV 16
Low risk
40
20
0
<25
26-35
36-45
>46
Age (years)
<
_ 25
26_35
36_45
>
_ 46
Total HPV +ve
68
126
30
15
No. of high-risk HPV
53
105
26
15
No. of low-risk HPV
17
22
3
0
No. of HPV16 (%)
42
72
24
14
Age (years)
Figure 2. (A) Prevalence of high- and low-risk HPV types among pre- and post-menopausal women. (B) Frequency of occurrence of
high-risk HPV types, HPV-16 and low-risk HPV types with increase in age.
Not much difference in the frequency of high and lowrisk HPV-type infection in different socio-demographic
factors was observed. But, with increase in age, an increase
in the frequency of oncogenic (high-risk) HPV-type
infection was observed, while the opposite is true for nononcogenic (low-risk) HPV types (figure 2B).
J. Biosci. 37(1), March 2012
The present study shows that the risk of HPV infection
increases significantly with residence in rural areas and
non-vegetarian diet, while other factors like increase in
age, parity, low income group and pregnancy might have
some influence although no association was observed
with young age and the age at first sexual intercourse.
High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern UP
4.
Discussion
In India, cervical cancer ranks first among all the female
malignancies, and as observed, it is mainly associated with
HPV infection. So HPV screening is one of the best ways to
check if a woman is at the risk of developing cervical cancer.
We have studied the overall HPV incidence in Varanasi and its
adjoining areas along with detecting different prevalent types
in this population.
A total of 2424 women, asymptomatic for any cervical
disease, were screened for HPV infection. 9.9% of the women
were found to be infected with either high- or low-risk HPV
types and some of them were co-infected with multiple HPV
types. This is in accordance with the other populations studied
in India (Bhatla et al. 2008; Kerkar et al. 2011) but different
from the data available from other countries. HPV infection
was reported to be 26.8% in the US (Dunne et al. 2007), 46%
in Gabon (Si-Mohamed et al. 2005), 13.3% in southeast
China (Ye et al. 2010), 15.1% in the UK (Cotton et al. 2007),
15.9% in Italy (Centurioni et al. 2005) and 21.25% in
American-Indian women (Bell et al. 2007).
Our study demonstrates that out of 26 different HPV
types detected, HPV-16 was the most prevalent, followed
by HPV-6 and -81. The frequency of HPV-16 as observed
in the population under study was 6.3% (figure 3), although
a lower prevalence rate (4.7%) was reported in southern
Asian countries (WHO 2010). Such a high frequency of
HPV-16 was not reported in other regions of India (Clifford
et al. 2005; Franceschi et al. 2005; Aggarwal et al. 2006;
Kerkar et al. 2011) but was reported in eastern Asia (6.4%)
and Eastern Europe (7.4%) (de Sanjose et al. 2007).
In this study we further tried to determine the association
of different socio-demographic factors with HPV infection.
69
We found that non-vegetarian diet and rural settings act as
significant independent predictors for HPV infection (also
reported earlier in north Indian population [Aggarwal et al.
2006]). Many studies reported that vegetarians have lower
risk of HPV infection because of the presence of fruits and
vegetables in their diet which are rich source of antioxidants
like vitamin C, E, β-carotene and presence of folate (or in
the form of folic acid) (Sedjo et al. 2002). Folate deficiency
is known to cause reduced immunity (Dhur et al. 1991). It
was found that women with high circulating concentration
of folate and β-carotene were twice as less likely to develop
persistent HPV infection and had greater likelihood of
clearing them, and also the women with lower folate level
and infected with high-risk type HPV-16 were 9 times more
likely to develop CIN-2+ (Piyathilake et al. 2010). It was
observed earlier by National Nutrition Monitoring Bureau,
India, that the level of these micronutrients were less in rural
population (Rao et al. 2010) and as observed in this study, the
frequency of HPV-16 was very high in the rural population.
Although we did not check the level of folate in these
samples, this may be one of the contributing factors towards
acquisition, persistence and progression of HPV infection.
In many studies young age (Verteramo et al. 2006; Datta
et al. 2010) and age at first intercourse (Flores et al. 2008)
were found to be associated with HPV infection but our
study demonstrated no such association with these factors.
In a study (Jacobs et al. 2000), it was reported that high-risk
HPV-type infection decreases with age while there was
constant prevalence of low-risk types. On the other hand,
our study indicated an increase in frequency of high-risk
HPV-type infection with increase in age and a decrease in
trend in the low-risk HPV type with increasing age. This may
be due to changes in immune and hormonal system in older
6.3
HPV 16
0.66
HPV 31
0.53
HPV 6
HPV 81
0.45
HPV 33
0.41
HPV 18
0.37
HPV 35
0.28
HPV 42
0.24
HPV 11
0.21
HPV 45
0.16
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
5.5
6
6.5
7
% of HPV prevalence
Figure 3. Ten most frequent HPV types observed in asymptomatic women of eastern UP, India.
J. Biosci. 37(1), March 2012
70
S Srivastava, S Gupta and JK Roy
women which impair clearing of HPV infection especially of the high-risk types. In younger age group women,
low and intermediate HPV types were more prevalent
than in older women, which may be due to the high
frequency of metaplastic changes taking place in the
cervix (Burd 2003). Further, in our study multiple types of
HPV infection were also observed in women of younger
age group only (≤30 years). It is yet to be seen if this
observation has a significance or is due to the limited
number of samples.
Association of HPV infection with post-menopausal
women (although not statistically significant) is being
shown in our study for the first time. Earlier reports (Althoff
et al. 2009) show persistent HPV infection in perimenopausal women mainly. As oestrogen is an important
immuno-modulating hormone and stimulator of humoral
immunity, an association of HPV with post-menopausal
women observed here may be due to lower oestrogen level
in post-menopausal women.
Further, in this study, pregnant women in their first
trimester of pregnancy were also included. Risk of HPV
infection was observed to be higher in them than in women
who were not pregnant. Since it is known that the level of
oestrogen was low in first trimester than in second and third
trimesters of pregnancy (Nobbenhuis et al. 2002), it is
likely that the low level of oestrogen is responsible for
reduced immunity.
In the present study, PCR-based method for HPV detection
was employed using two primer sets, GP5+/6+ and MY09/11,
both of them belonging to the L1 consensus region. Since these
primers can detect a large spectrum of HPV types, they were
used most frequently for HPV detection, but there is also a
drawback in using them. In most of the cases, integration of
HPV takes place by disrupting L1, E1 or E2 regions, hence
making these disrupted regions unamplified and assessing them
as false HPV-negative, consequently leading to underestimation
of the prevalence. So, including other regions (E6/E7/LCR) for
the detection of HPV may be beneficial, but since we obtained a
comparable frequency of HPV-16-positive individuals in our
study and in studies reported from other labs on asymptomatic
populations, as well as in cervical cancer samples (not included
in this study), it is likely that our result gives a true
representation of the population.
In India there is lack of screening programmes
because of which large numbers of women remain
undetected for HPV infection and cervical lesions in
their initial stages. As this study shows that old age
group women possess higher frequency of HPV infection, this emphasizes that these women should not be
spared from screening.
Further, the information generated by the study regarding the
distribution of different HPV types in this population is
significant and can be used for proper utilization of the present
J. Biosci. 37(1), March 2012
prophylactic vaccines or for the generation of a new vaccine
against a set of HPV types. Currently developed prophylactic
vaccines are bivalent (Cervarix, GlaxoSmithKline Biologicals)
and quadrivalent (Gardasil, Merck & Co.), which target only a
set of HPV types 16/18 or 16/18/6/11, respectively. Although
these vaccines can reduce the cervical cancer incidence, for the
efficacy of the vaccines it is important to know the prevalence of
different HPV types in the given population to be immunized. In
UP, there was no epidemiological data of cervical cancer from
National Cancer Registry Programme (NCRP) established by
Indian Council for Medical Research (India), but a study
including population of the districts Mahoba, Lalitpur, Agra and
Banda have been shown to have highest prevalence of cervical
cancer among all the female malignancies, although HPV
genotypes are not known (Ganjewala 2009). Crude Incidence
Rate (CIR) for cervical cancer was observed to be very high in
Mahoba and Banda (28.83 and 27.63 per 100,000 persons,
respectively) (Ganjewala 2009). Also the population of eastern
UP covered under this study is exposed more to HPV-16, 31,
33, 6 and 81; hence, there is a need for vaccination covering
these types. The study showed high frequency of HPV-16 in
the given population, indicating an increase in risk of CINs in
future, and hence there is an urgent need for the development
of a therapeutic vaccine for this region.
Acknowledgements
We are grateful to the hospital staff of PP-ODP for their cooperation in cervical scrape sample collection. We thank Dr
Attila Lorincz for providing us clones of HPV-31 and HPV-35
and Dr Gerard Orth for the clone of HPV-33. We also thank
Prof KK Singh and Ms Shilpi for their help with statistics. The
help of Dr MR Pillai in re-examining HPV genotypes of some
randomly chosen samples, is duly acknowledged. This study
was supported by the grant from Department of Biotechnology,
India.
References
Aggarwal R, Gupta S, Nijhawan R, Suri V, Kaur A, Bhasin V
and Arora SK 2006 Prevalence of high-risk human papillomavirus infections in women with benign cervical cytology: a
hospital based study from North India. Indian J. Cancer 43
110–116
Althoff KN, Paul P, Burke AE, Viscidi R, Angaramoorthy M and
Gravitt PE 2009 Correlates of cervicovaginal human papillomavirus detection in perimenopausal women. J. Women. Health
18 1341–1346
Baay MF, Quint WG, Koudstaal J, Hollema H, Duk JM, Burger
MP, Stolz E and Herbrink P 1996 Comprehensive study of
several general and type-specific primer pairs for detection of
human papillomavirus DNA by PCR in paraffin-embedded
cervical carcinomas. J. Clin. Microbiol. 34 745–747
High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern UP
Bell MC, Schmidt-Grimminger D, Patrick S, Ryschon T, Linz L
and Chauhan SC 2007 There is a high prevalence of human
papillomavirus infection in American Indian women of the
Northern Plains. Gynecol. Oncol. 107 236–241
Bhatla N, Dar L, Patro AR, Kumar P, Pati SK, Kriplani A, Gulati
A, Broor S, et al. 2008 Human papillomavirus-type distribution
in women with and without cervical neoplasia in north India.
Int. J. Gynecol. Pathol. 27 426–430
Burd EM 2003 Human papillomavirus and cervical cancer. Clin.
Microbiol. Rev. 16 1–17
Centurioni MG, Puppo A, Merlo DF, Pasciucco G, Cusimano ER,
Sirito R and Gustavino CA 2005 Prevalence of human
papillomavirus cervical infection in an Italian asymptomatic
population. BMC Infect. Dis. 5 77
Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJF,
Vaccarella S, Anh PT, Ferreccio C, et al. 2005 Worldwide
distribution of human papillomavirus types in cytologically
normal women in the International Agency for Research on
Cancer HPV prevalence surveys: a pooled analysis. Lancet 366
991–998
Cotton SC, Sharp L, Seth R, Masson LF, Little J, Cruickshank
ME, Neal K, Waugh N and TOMBOLA Group 2007
Lifestyle and socio-demographic factors associated with
high-risk HPV infection in UK women. Br. J. Cancer 97
133–139
Datta P, Bhatla N, Dar L, Patro A R, Gulati A, Kriplani A and
Singh N 2010 Prevalence of human papillomavirus infection
among young women in North India. Cancer Epidemiol. 34
157–161
de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz
N and Bosch FX 2007 Worldwide prevalence and genotype
distribution of cervical human papillomavirus DNA in women
with normal cytology: a meta-analysis. Lancet Infect. Dis. 7
453–459
Dhur A, Galan P and Hercberg S 1991 Folate status and the
immune system. Prog. Food Nutr. Sci. 15 43–60
Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC,
Patel SS and Markowitz LE 2007 Prevalence of HPV
infection among females in the United States. JAMA 297
813–819
Evans MF, Adamson CSC, Simmons-Arnold L and Cooper K
2005 Touchdown General Primer (GP5+/GP6+) PCR and
optimized sample DNA concentration support the sensitive
detection of human papillomavirus. BMC Clin. Pathol. 5
10
Flores YN, Bishai DM, Shah KV, Lazcano-Ponce E, Lörincz A,
Hernández M, Ferris D and Salmerón J 2008 Risk factors for
cervical cancer among HPV positive women in Mexico. Salud
Publica Mex. 50 49–58
Franceschi S, Rajkumar R, Snijders PJF, Arslan A, Mahe C,
Plummer M, Sankaranarayanan R, Cherian J, Meijer CJLM and
Weiderpass E 2005 Papillomavirus infection in rural women in
southern India. Br. J. Cancer 92 601–606
Ganjewala D 2009 Prevalence of cancers in some parts of Madhya
Pradesh and Uttar Pradesh in India. Acad. J. Cancer Res. 2 12–
18
Gravitt PE, Peyton CL, Apple RJ and Wheeler CM 1998
Genotyping of 27 Human Papillomavirus types by using L1
71
consensus PCR products by a single-hybridization, Reverse
Line Blot detection method. J. Clin. Microbiol. 36 3020–
3027
Jacobs MV, Walboomers JMM, Snijders PJF, Voorhorst FJ,
Verheijen RHM, Fransen-Daalmeijer N and Meijer CJLM 2000
Distribution of 37 mucosotropic HPV types in women with
cytologically normal Cervical Smears: the age-related patterns for
high-risk and low-risk types. Int. J. Cancer 87 221–227
Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G,
Holm R, Johansson B and Hagmar B 1996 Use of multiple PCR
primer sets for optimal detection of human papillomavirus.
J. Clin. Microbiol. 34 2095–2100
Kerkar SC, Latta S, Salvi V and Pramanik JM 2011 Human
Papillomavirus infection in asymptomatic population. Sex.
Reprod. Health. 2 7–11
Lee SH, Vigliotti VS, Vigliotti JS and Pappu S 2009 Validation of
human papillomavirus genotyping by signature DNA sequence
analysis. BMC Clin. Pathol. 9 3
Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X,
Shah KV, Snijders PJF and Meijer CJLM 2003 International
Agency for Research on Cancer Multicenter cervical Cancer
Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl. J.
Med. 348 518–527
Nobbenhuis MAE, Helmerhorst TJM, Van Den Brule AJC,
Rozendaal L, Bezemer PD, Voorhorst FJ and Meijer CJLM
2002 High-risk human papillomavirus clearance in pregnant
women: trends for lower clearance during pregnancy with a
catch-up postpartum. Br. J. Cancer 87 75–80
Ostor AG 1993 Natural history of cervical intraepithelial neoplasia:
a critical review. Int. J. Gynecol. Pathol. 12 186–192
Piyathilake CJ, Badiga S, Paul P, Vijayaraghavan K, Vedantham
H, Sudula M, Sowjanya P, Ramakrishna G, Shah KV, Partridge
EE and Gravitt PE 2010 Indian women with higher serum
concentrations of folate and vitamin B12 are significantly less
likely to be infected with carcinogenic or high-risk (HR) types of
human papillomaviruses (HPVs). Int. J. Women. Health 2 7–12
Rao KM, Balakrishna N, Arlappa N, Laxmaiah A and Brahmam
GNV 2010 Diet and Nutritional Status of Women in India.
J. Hum. Ecol. 29 165–170
Sedjo RL, Roe DJ, Abrahamsen M, Harris RB, Craft N, Baldwin S
and Giuliano AR 2002 Vitamin A, carotenoids, and risk of
persistent oncogenic human papillomavirus infection. Cancer
Epidemiol. Biomarkers Prev. 11 876–884
Si-Mohamed A, Ndjoyi-Mbiguino A, Cuschieri K, Onas IN,
Colombet I, Ozouaki F, Goff JL, Cubie H and Belec L 2005
High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing
age living in Libreville, Gabon. J. Med. Virol. 430–438
Trottier H, Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E,
Rohan TE, Ferenczy A, Villa LL and Franco EL 2006 Human
papillomavirus infections with multiple types and risk of
cervical neoplasia. Cancer Epidemiol. Biomarkers Prev. 15
1274–1280
Verteramo R, Pierangeli A, Calzolari E, Patella A, Recine N,
Mancini E, Marcone V, Masciangelo R, et al. 2006 Direct
sequencing of HPV DNA detected in gynaecologic outpatients
in Rome, Italy. Microbes Infect. 8 2517–2521
J. Biosci. 37(1), March 2012
72
S Srivastava, S Gupta and JK Roy
Vinayagamoorthy T, Mulatz K and Hodkinson R 2003 Nucleotide
sequence-based multitarget identification. J. Clin. Microbiol.
413284–3292
Vossler JL, Forbes BA and Adelson MD 1995 Evaluation of the
polymerase chain reaction for the detection of human papillomavirus from urine. J. Med. Virol. 45 354–360
WHO/ICO Information Centre on HPV and Cervical Cancer (HPV
Information Centre) 2010 Human papillomavirus and related
cancers in India. Summary Report 2010
Ye J, Cheng X, Chen X, Ye F, Lu W and Xie X 2010 Prevalence and
risk profile of cervical human papillomavirus infection in Zhejiang
Province, southeast China: a population-based study. Virol. J. 7 66
MS received 20 October 2011; accepted 29 December 2011
Corresponding editor: RITA MULHERKAR
:
J. Biosci. 37(1), March 2012